Literature DB >> 4154950

Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.

M A Weber, G S Stokes, J M Gain.   

Abstract

Continuous 6-h infusions of the beta adrenergic blockers d,l-propranolol or oxprenolol significantly reduced plasma renin activity (PRA) and mean blood pressure in the resting rabbit and prevented the stimulatory effects of isoproterenol on renin release and heart rate. These actions were due to blockade of beta receptors, for the inactive isomer, d-propranolol, had no effect. Despite sustained high plasma concentrations of d,l-propranolol (0.2 mug/ml) in the unstimulated animal, PRA did not fall below 36% of control values, suggesting that basal renin secretion is maintained partly by factors other than beta adrenergic mechanisms.Prindolol, another beta blocker, also abolished the effects of isoproterenol on renin and on the heart, and reduced blood pressure in the resting animal. However, prindolol increased resting PRA and heart rate, and in animals already receiving d,l-propranolol, it raised PRA and heart rate without further altering blood pressure. This suggests that the effect on PRA of prindolol was due to its intrinsic sympathomimetic activity and not hypotension-mediated mechanisms. The observation that the blood pressure-lowering effect of prindolol was associated with a rise in PRA, while another beta antagonist, H 35/25, lowered PRA but had no effect on blood pressure, indicates that the hypotensive action of beta blockers is unrelated to their effects on renin release. In both unstimulated and isoproterenol-challenged animals, only blockers possessing beta-1 receptor affinity (d,l-propranolol, oxprenolol, prindolol, practolol, and metoprolol) affected heart rate, while effects on PRA were more prominent with agents possessing beta-2 activity (d,l-propranolol, oxprenolol, prindolol, and H 35/25). Thus, the changes in PRA caused by the beta adrenergic blockers appear to be dependent upon the summation of their direct effects, antagonistic or sympathomimetic, on beta-2 adrenergic receptors regulating renin release.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4154950      PMCID: PMC301696          DOI: 10.1172/JCI107888

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

2.  Adrenergic receptor mediation of renin secretion.

Authors:  N Winer; D S Chokshi; M S Yoon; A D Freedman
Journal:  J Clin Endocrinol Metab       Date:  1969-09       Impact factor: 5.958

Review 3.  Clinical pharmacology of beta-receptor-blocking drugs.

Authors:  C T Dollery; J W Paterson; M E Conolly
Journal:  Clin Pharmacol Ther       Date:  1969 Nov-Dec       Impact factor: 6.875

4.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

5.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

6.  Direct effects of potassium on renin secretion and renal function.

Authors:  A J Vander
Journal:  Am J Physiol       Date:  1970-08

7.  Beta adrenergic stimulation of insulin release in man.

Authors:  D Porte
Journal:  Diabetes       Date:  1967-03       Impact factor: 9.461

8.  Effect of catecholamines and the renal nerves on renin secretion in anesthetized dogs.

Authors:  A J Vander
Journal:  Am J Physiol       Date:  1965-09

9.  Differentiation of receptor systems activated by sympathomimetic amines.

Authors:  A M Lands; A Arnold; J P McAuliff; F P Luduena; T G Brown
Journal:  Nature       Date:  1967-05-06       Impact factor: 49.962

10.  A method for the fluorimetric determination of 4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB46), a beta-blocking agent, in plasma and urine.

Authors:  W L Pacha
Journal:  Experientia       Date:  1969-08-15
View more
  20 in total

1.  The role of renin in the antihypertensive action of beta-adrenoreceptor blocking agents.

Authors:  G S Stokes; R M Graham; M A Weber
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 2.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

3.  Effects of salbutamol and metoprolol on plasma renin activity and plasma potassium of normal subjects and of hypertensive patients.

Authors:  A Salvetti; L Poli; F Arzilli; L Sassano; R Pedrinelli; M Motolese
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

4.  [Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)].

Authors:  K O Stumpe; H Vetter; V Hessenbruch; R Düsing; R Kolloch; F Krück
Journal:  Klin Wochenschr       Date:  1975-10-01

Review 5.  Treating hypertension. The place of beta blockade.

Authors:  D W Barritt; A J Marshall
Journal:  Br Heart J       Date:  1977-08

6.  Antihypertensive action of beta-adrenoceptor blockade and the renin-angiotensin system.

Authors:  I Gavras; H Gavras; H R Brunner; C S Liang
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

7.  [Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)].

Authors:  P Weidmann; C Beretta-Piccoli; W Ziegler; D Hirsch; R D de Châtel; F C Reubi
Journal:  Klin Wochenschr       Date:  1976-08-15

8.  Effect of beta adrenergic blockade on renin response to renal nerve stimulation.

Authors:  M S Taher; L G McLain; K M McDonald; R W Schrier; L K Gilbert; G A Aisenbrey; A L McCool
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

Review 9.  Neurogenic aspects of essential hypertension in man.

Authors:  G A FitzGerald
Journal:  Ir J Med Sci       Date:  1979-12       Impact factor: 1.568

Review 10.  Effect of antihypertensive drugs on the renin-angiotensin system.

Authors:  C I Johnston
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.